{"SPADE_UN_00235": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_00235", "Peptide Name": "Lumbricin I(6–34)", "Source": "Synthetic construct (derived from residues 6–34 of lumbricin I)", "Family": "Not found", "Gene": "Not found", "Sequence": "RQKDKRPYSERKNQYTGPQFLYPPERIPPQKVIK", "Sequence Length": 34, "UniProt Entry": ["http://www.uniprot.org/uniprot/O96447"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-", "Antifungal"], "Target Organism": "[Ref.9784609]Gram-positive bacteria:Bacillus subtilis ATCC 62037 (MIC=8 µg/ml), Staphylococcus aureus ATCC 15752 (MIC=12 µg/ml), Streptococcus mutans ATCC 25175 (MIC=20 µg/ml);Gram-negative bacteria:Escherichia coli ATCC 27325 (MIC=8 µg/ml), Pseudomonas putidaATCC 17426 (MIC=12 µg/ml), Serratia sp. ATCC 21074 (MIC=12 µg/ml).Fungi:Candida albicans ATCC 10231 (MIC=12 µg/ml), Cryptococcus neoformance ATCC 34881 (MIC=16 µg/ml), Saccharomyces cerevisiae ATCC 44774 (MIC=8 µg/ml).NOTE:Minimal inhibitory concentrations were determined by incubating approximately 104–105 CFU/ml of cells with serial dilutions of each peptide in a 96-well microtiter plate..", "Hemolytic Activity": "[Ref.9784609]0.03% hemolytic activity at 5 μg/ml, 0.07% hemolytic activity at 10 μg/ml, 0.13% hemolytic activity at 25 μg/ml, 0.17% hemolytic activity at 50 μg/ml, 0.21% hemolytic activity at 100 μg/ml against human erythrocytes", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C190H302N56O51", "Mass": 4186.78, "PI": 10.21, "Net Charge": 6, "Hydrophobicity": -1.8, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Function": "Lumbricin I(6-34) has marginally stronger antimicrobial activities than lumbricin I. Has weak hemolytic activity  when tested against human erythrocytes.", "Literature": [{"Title": "Lumbricin I, a novel proline-rich antimicrobial peptide from the earthworm purification, cDNA cloning and molecular characterization.", "Pubmed ID": "9784609", "Reference": "Biochim Biophys Acta. 1998 Oct 22;1408(1)67-76.", "Author": "Cho JH, Park CB, Yoon YG, Kim SC.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=9784609"}], "Frequent Amino Acids": "PKQ", "Absent Amino Acids": "ACHMOUW", "Basic Residues": 9, "Acidic Residues": 3, "Hydrophobic Residues": 14, "Polar Residues": 20, "Positive Residues": 9, "Negative Residues": 3, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02117", "Similarity": 1.0, "Sequence": "FSKYERQKDKRPYSERKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA"}, {"SPADE_ID": "SPADE_N_02429", "Similarity": 1.0, "Sequence": "RQKDKRPYSERKNQYTGPQFLYPPERIPP"}, {"SPADE_ID": "SPADE_UN_08626", "Similarity": 1.0, "Sequence": "MSLCISDYLYLTLTFSKYERQKDKRPYSERKNQYTGPQFLYPPERIPPQKVIKWNEEGLPIYEIPGEGGHAEPAAA"}]}}}